NEW YORK (GenomeWeb) – Protagen said today that it is collaborating with the German National Center for Tumor Diseases (NCT) Heidelberg to identify biomarkers for predicting response to immunotherapy in melanoma patients.

The work will use Protagen's SeroTag platform, which simultaneously measures autoantibody levels for thousands of antigens to detect expression patterns linked to disease or patient response to particular therapies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.